Z-1492-2025 Class II Ongoing

Recalled by Terumo Cardiovascular Systems Corporation — Ann Arbor, MI

FDA device recall Z-1492-2025 was initiated by Terumo Cardiovascular Systems Corporation on March 3, 2025 and is designated Class II. Reason for recall: During some clinical cases, it has been observed that the SO2 value may periodically appear as dashes on the Touchscreen Display indicating unavailable data. In these cases, a yellow low-limit alarm… The recall status is ongoing. Affected quantity: 37 units.

Recall Details

Product Type
Devices
Report Date
April 9, 2025
Initiation Date
March 3, 2025
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
37 units

Product Description

Terumo CDI OneView Monitoring System Hematocrit / Oxygen Saturation Probe, Catalog Number REF CD1754

Reason for Recall

During some clinical cases, it has been observed that the SO2 value may periodically appear as dashes on the Touchscreen Display indicating unavailable data. In these cases, a yellow low-limit alarm will also be triggered to the user, due to the dashed-out value.

Distribution Pattern

US: IL, TX, NY, MI, FL, NV, and Australia, New Zealand

Code Information

UDI/DI 00886799001882, Serial Number range: H0050095-H0050110, H0050112-H0050116, H0050118-H0050124, H0050126, H0050131-H0050134, H0050136, H0050140-H0050142